跳至主要内容
临床试验/NL-OMON37674
NL-OMON37674已完成不适用

Clinical evaluation of the underlying mechanisms of targeted therapy related toxicities - mechanisms of toxicity of targeted agents

Vrije Universiteit Medisch Centrum0 个研究点目标入组 120 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Patients that will start palliative treatment with TKIs, mTOR inhibitors, ipilimumab, vemurafenib or anti-EGFR antibodies and therefore fulfill according to their attending physician all the usual criteria for receiving standard targeted therapy as monotherapy.
  • 2. PT-INR/PTT < 1.5 x ULN.
  • 3. Platelet count > 100 x 109/l

排除标准

  • * Concomitant use of anticoagulants
  • * Previous colonic surgery in the last 3 months
  • * History of inflammatory bowel disease, or other active gastrointestinal infection

研究者

相似试验